Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Demographic data of subjects

From: Bioequivalence study of three ibuprofen formulations after single dose administration in healthy volunteers

Parameter Sequence N Mean SD Median Range
Age (years) BE 20 23.9 3.65 23.5 20; 35
  EA 20 25.1 5.01 24.0 20; 39
  AEB 20 27.8 6.57 26.5 20; 45
Weight (kg) BE 20 68.3 10.74 69.5 50; 90
  EA 20 67.7 9.54 68.5 49; 82
  AEB 20 67.9 10.48 68.0 52; 87
BMI (kg/m2) * BE 20 22.8 2.40 23.0 19; 27
  EA 20 22.9 2.29 23.0 19; 27
  AEB 20 22.2 2.67 22.0 19; 27
  Sequence N N (♀) % (♀) N (♂) % (♂)
Female gender (%) BE 20 7 35.0 13 65.0
  EA 20 6 30.0 14 70.0
  AEB 20 6 30.0 14 70.0
  1. Demography and other baseline characteristics by treatment sequence (Pharmacokinetic population; N = 60). "A" refers to Nurofen® forte, "B" refers to Migränin® and "E" refers to Eudorlin® extra. * calculated from measured height (m) and weight (kg).